Releases

Media coverage

Newsletter

Subscribe to our newsletter

Archive


Mar 21, 2016
Positive editorial discussion in the Journal: Cell Cycle, focusing on LTX-315 as a cationic anticancer peptide (CAP)  which is “CAPtivating immunity with necrosis”.

Read article